<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://regulatorynews.com/orthopediatrics-pnp-femur-retrograde-fda-clearance</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-02T09:07:15-05:00</news:publication_date>
      <news:title>OrthoPediatrics Wins FDA Clearance for Retrograde Femur Nail</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/fda-syd-101-myopia-adcomm</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-02T05:00:41-05:00</news:publication_date>
      <news:title>FDA Panel Backs Denial of Pediatric Myopia Drops</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/mhra-dojolvi-triheptanoin-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-02T05:00:41-05:00</news:publication_date>
      <news:title>MHRA Approves Dojolvi for Long-Chain Fatty-Acid Disorders</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/mht-patch-boxed-warning-physicians</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-01T09:53:05-05:00</news:publication_date>
      <news:title>FDA Narrows Menopause Hormone Therapy&apos;s Boxed Warning</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/element-biosciences-aviti-dx-ce-mark</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-01T08:38:47-05:00</news:publication_date>
      <news:title>Element Biosciences Launches CE-Marked AVITI Dx</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/nrx-pharmaceuticals-ketamine-fda-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-01T08:38:47-05:00</news:publication_date>
      <news:title>NRx Pharmaceuticals Secures FDA Nod for Ketamine Drug</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/pharaoh-neuro-neurapheresis-breakthrough-device</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-01T08:38:47-05:00</news:publication_date>
      <news:title>Pharaoh Neuro Wins FDA Breakthrough Tag for CSF Device</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/ema-prac-immunoglobulin-deanxit-safety-review</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-01T05:01:45-05:00</news:publication_date>
      <news:title>EMA Opens Safety Review of Immunoglobulin Batches</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/fda-estradiol-patch-boxed-warning-update</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-01T05:01:45-05:00</news:publication_date>
      <news:title>FDA Eases Boxed Warning on 3 More Estrogen Patches</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/fda-spinal-imaging-system-classification</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-01T05:01:45-05:00</news:publication_date>
      <news:title>FDA Sets a Class II Path for Spinal-Imaging Devices</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/casgevy-pediatric-hematology-physicians</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T10:49:31-04:00</news:publication_date>
      <news:title>MHRA Lowers Casgevy&apos;s Age Floor to Five; FDA&apos;s Is Two</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://regulatorynews.com/voceryq-rrp-otolaryngology-physicians</loc>
    <news:news>
      <news:publication>
        <news:name>Regulatory News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T10:49:31-04:00</news:publication_date>
      <news:title>FDA Approves Voceryq, a DNA Immunotherapy for RRP</news:title>
    </news:news>
  </url>
</urlset>
